Show simple item record

dc.contributor.authorCela López, José M.
dc.contributor.authorCamacho Roldán, Claudio J.
dc.contributor.authorGómez Lizarraga, Gorka
dc.contributor.authorMartínez, Vicente
dc.date.accessioned2021-08-10T12:23:25Z
dc.date.available2021-08-10T12:23:25Z
dc.date.issued2021-07-28
dc.identifier.citationMolecules 26(15) : (2021) // Article ID 4564
dc.identifier.issn1420-3049
dc.identifier.urihttp://hdl.handle.net/10810/52817
dc.description.abstractGenito-urinary tract infections have a high incidence in the general population, being more prevalent among women than men. These diseases are usually treated with antibiotics, but very frequently, they are recurrent and lead to the creation of resistance and are associated with increased morbidity and mortality. For this reason, it is necessary to develop new compounds for their treatment. In this work, our objective is to review the characteristics of the compounds of a new formulation called Itxasol© that is prescribed as an adjuvant for the treatment of UTIs and composed of β-arbutin, umbelliferon and n-acetyl cysteine. This formulation, based on biomimetic principles, makes Itxasol© a broad-spectrum antibiotic with bactericidal, bacteriostatic and antifungal properties that is capable of destroying the biofilm and stopping its formation. It also acts as an anti-inflammatory agent, without the adverse effects associated with the recurrent use of antibiotics that leads to renal nephrotoxicity and other side effects. All these characteristics make Itxasol© an ideal candidate for the treatment of UTIs since it behaves like an antibiotic and with better characteristics than other adjuvants, such as D-mannose and cranberry extracts.
dc.language.isoeng
dc.publisherMDPI
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjecturinary tract infections
dc.subjectarbutin
dc.subjectumbelliferon
dc.subjectN-acetyl l-cysteine
dc.titleA Natural Alternative Treatment for Urinary Tract Infections: Itxasol©, the Importance of the Formulation
dc.typeinfo:eu-repo/semantics/article
dc.date.updated2021-08-06T15:19:25Z
dc.rights.holder(cc) 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
dc.identifier.doi10.3390/molecules26154564


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

(cc) 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as (cc) 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).